Andrzej Horban Selected Research

Therapeutics

1/2022	The Presence of Either Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients from a Multinational Observational Study: Data from Euroguidelines in Central and Eastern Europe Network Group.
11/2021	Diagnosis and therapy of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of November 12, 2021. Annex no. 1 to the Recommendations of April 26, 2021.
2/2021	Is age and not antiretroviral therapy the strongest risk factor for chronic pain in HIV-infected population?
1/2021	Tocilizumab for patients with severe COVID-19: a retrospective, multi-center study.
1/2020	Differences and similarities in clinical manifestations of Listeria monocytogenes and Mycobacterium tuberculous meningitis.
9/2019	Effect of comedication on ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin therapy in chronic hepatitis C - a real-world study.
1/2019	Real-life study of dual therapy based on dolutegravir and ritonavir-boosted darunavir in HIV-1-infected treatment-experienced patients.
1/2019	Non-AIDS defining bacterial infections in patients with HIV infection
1/2018	Is Interferon-Based Treatment of Viral Hepatitis C Genotype 3 Infection Still of Value in the Era of Direct-Acting Antivirals?
1/2018	Inflammation-Related Morbidity and Mortality Among HIV-Positive Adults: How Extensive Is It?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrzej Horban Research Topics

Disease

28	Infections 04/2022 - 01/2004
17	Chronic Hepatitis C 07/2020 - 01/2005
8	Fibrosis (Cirrhosis) 01/2021 - 01/2006
7	COVID-19 04/2022 - 08/2020
7	Liver Diseases (Liver Disease) 11/2019 - 09/2005
7	Hepatitis C 01/2018 - 01/2005
7	Chronic Hepatitis B 01/2017 - 01/2006
5	HIV Infections (HIV Infection) 02/2021 - 06/2007
3	Communicable Diseases (Infectious Diseases) 04/2022 - 01/2010
3	Sepsis (Septicemia) 01/2021 - 01/2018
3	Liver Cirrhosis (Hepatic Cirrhosis) 07/2020 - 09/2015
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 09/2005
2	Coinfection 01/2022 - 01/2014
2	Meningeal Tuberculosis (Tuberculous Meningitis) 01/2020 - 09/2017
2	Neoplasms (Cancer) 10/2019 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2019 - 01/2018
2	Proteinuria 01/2019 - 01/2017
2	Encephalitis (Encephalitis, Rasmussen) 10/2018 - 01/2017
2	Needlestick Injuries (Needlestick Injury) 04/2018 - 01/2014
2	Virus Diseases (Viral Diseases) 01/2018 - 01/2016
2	Human Influenza (Influenza) 07/2013 - 01/2010
2	Anemia 06/2011 - 01/2006
2	Renal Insufficiency (Renal Failure) 01/2006 - 01/2006
2	Disease Progression 09/2005 - 01/2005
2	Coronary Disease (Coronary Heart Disease) 01/2005 - 10/2004
1	Hypersensitivity (Allergy) 12/2021
1	Chronic Pain 02/2021
1	Disseminated Intravascular Coagulation 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Clinical Deterioration 08/2020
1	Paresis (Hemiparesis) 01/2020
1	Aphasia (Dysphasia) 01/2020
1	Hydrocephalus (Hydrocephaly) 01/2020
1	Meningitis 01/2020
1	Vomiting 11/2019
1	Alcoholism (Alcohol Abuse) 11/2019
1	Nausea 11/2019
1	Headache (Headaches) 11/2019
1	Kidney Diseases (Kidney Disease) 03/2019

Drug/Important Bio-Agent (IBA)

18	Ribavirin (Virazole)FDA LinkGeneric 09/2019 - 01/2005
11	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2011
10	RNA (Ribonucleic Acid)IBA 01/2018 - 10/2004
8	InterferonsIBA 01/2018 - 01/2005
7	Pharmaceutical PreparationsIBA 02/2021 - 09/2005
7	Lamivudine (Epivir)FDA Link 01/2017 - 01/2006
6	telaprevirIBA 01/2016 - 06/2011
5	DNA (Deoxyribonucleic Acid)IBA 09/2019 - 10/2011
5	Tenofovir (Viread)FDA Link 01/2017 - 01/2011
5	peginterferon alfa-2a (Pegasys)FDA Link 01/2015 - 01/2005
3	SimeprevirIBA 01/2018 - 06/2014
3	Emtricitabine (Emtriva)FDA Link 01/2017 - 01/2011
3	peginterferon alfa-2b (Pegintron)FDA Link 09/2014 - 01/2005
3	Reverse Transcriptase InhibitorsIBA 07/2014 - 10/2004
3	Protease Inhibitors (Protease Inhibitor)IBA 09/2009 - 10/2004
2	Zidovudine (Retrovir)FDA LinkGeneric 02/2021 - 03/2010
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2021 - 08/2020
2	tocilizumab (atlizumab)FDA Link 01/2021 - 08/2020
2	Ritonavir (Norvir)FDA Link 09/2019 - 11/2011
2	AntigensIBA 10/2018 - 01/2006
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2004
2	RacivirIBA 01/2017 - 01/2011
2	efavirenz (Sustiva)FDA Link 01/2016 - 03/2010
2	5' Untranslated Regions (5' UTR)IBA 01/2015 - 01/2014
2	NucleosidesIBA 07/2014 - 10/2004
2	insulin receptor-related receptor (IRR)IBA 01/2012 - 09/2005
2	Maraviroc FDA Link 03/2010 - 10/2008
2	Oseltamivir (Tamiflu)FDA Link 01/2010 - 01/2010
2	Cyclophilins (Cyclophilin)IBA 05/2009 - 03/2008
2	Hepatitis B e AntigensIBA 01/2006 - 01/2006
1	AntibodiesIBA 04/2022
1	COVID-19 vaccine booster shotIBA 04/2022
1	VaccinesIBA 04/2022
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022
1	molnupiravirIBA 01/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022
1	nirmatrelvir and ritonavir drug combinationIBA 01/2022
1	IntegrasesIBA 12/2021
1	Stavudine (Zerit)FDA LinkGeneric 02/2021
1	Dacarbazine (DIC)FDA LinkGeneric 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	elbasvirIBA 07/2020
1	grazoprevirIBA 07/2020
1	ProcalcitoninIBA 01/2020
1	Urea (Carbamide)FDA LinkGeneric 11/2019
1	Transaminases (Aminotransferases)IBA 11/2019
1	Glucose (Dextrose)FDA LinkGeneric 11/2019
1	dasabuvirIBA 09/2019
1	paritaprevirIBA 09/2019
1	ombitasvirIBA 09/2019
1	Methadone (Dolophine)FDA LinkGeneric 03/2019
1	CholesterolIBA 01/2019

Therapy/Procedure

20	Therapeutics 01/2022 - 01/2005
3	Artificial Respiration (Mechanical Ventilation) 01/2021 - 01/2010
2	Blood Transfusion (Blood Transfusions) 11/2019 - 11/2011
2	First Aid (Aids, First) 04/2018 - 01/2014
2	Highly Active Antiretroviral Therapy (HAART) 01/2015 - 09/2005
1	Art Therapy 02/2021
1	Organ Transplantation 10/2019
1	Polypharmacy 09/2019